Elevance Health Inc
ELV: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|D> | LOCK|>>h^% | LOCK|cVhTgL> |
Elevance Earnings: Higher 2026 Outlook Mildly Boosts Shares
Elevance reported first-quarter results including 2% revenue growth and adjusted EPS of $12.58, well above FactSet consensus of $11.03, albeit helped by $1 of nonrecurring investment income. The company raised its 2026 adjusted EPS guidance to at least $26.75, up from at least $25.50.
